Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

November 18, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Priority Review for Pfizer’s tick-borne encephalitis vaccine in the US

New Research Reveals Androgen Receptor promotes Cancer

Sea Snail Venom can help to cure Malaria

Priority Review for Pfizer’s tick-borne encephalitis vaccine in the US
  • BiotechToday
  • World

Priority Review for Pfizer’s tick-borne encephalitis vaccine in the US

bioxone March 4, 2021March 4, 2021

Devyani Goswami, Amity University Kolkata

Nanette Cocero, global president, vaccines, of Pfizer announced that their tick-borne encephalitis vaccine (TBE) has been approved for a priority review from the US Food and Drug Administration (FDA). 

Once approved the vaccine promises to cure tick-borne encephalitis epidemics all across the US. The vaccine has to be subjected twice in a life-time to develop immunity. The clinical trials performed showed 96-99% immunity development across two ages of development 1- 15 years old and 16-65 years old. The vaccine is considered to be more effective on people who were given two doses of it. 

Pfizer waits for the approval, which said to declared in August 2021, six months after the application submission date. Once they get the prescription drug user fee act (PDUFA), they would be stated that this would further improve the condition of people suffering from severe conditions.

Also read:New Research Reveals Androgen Receptor promotes Cancer

Source: https://www.pfizer.com/news/press-release/press-release-detail/us-fda-accepts-priority-review-pfizers-application

  • Why Do We Age? The Biology Of Ageing Explained
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged Food and Drug Administration (FDA) Pfizer prescription drug user fee act (PDUFA) priority review tick-borne encephalitis vaccine (TBE) US VACCINE

One thought on “Priority Review for Pfizer’s tick-borne encephalitis vaccine in the US”

  1. Pingback: Sea Snail Venom can help to cure Malaria - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Sea Snail Venom can help to cure Malaria

bioxone March 4, 2021

Sayak Banerjee, Amity University Kolkata The toxin of the cone-like ocean snail (Conus nux) was used to manufacture medicines against intense fever and forms of infections in step with research from the Florida Atlantic University (FAU) School of Medication. The researchers as a team started from the likelihood that non-stick medications could be the way […]

Snail

Related Post

  • BiotechToday
  • World

New AI technology aids to cater to ozone problems!

bioxone June 26, 2021June 25, 2021

Avani Dave, Jai Hind College The current technology can accurately prognosticate the ozone levels in the troposphere of the earth, just 3 days in advance. This seemed sufficient until technology took a leap, birthing the latest discovery that promises an accurate forecast around 2 weeks prior. The birthplace of this system was in The University […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Nanopores – As Single-Molecule Sensors

bioxone November 15, 2020November 15, 2020

Surupa Chakraborty, Amity University Kolkata The past decade saw an explosion in the use of nanopore-based technology for DNA/RNA sequencing where Nanopores can be ideally used as single-molecule sensors. Oxford Nanopore Technologies has developed sequencing technologies – the ION series; a miniature nanopore DNA sequencer called the MinION that allows portable and convenient sequencing of high throughput […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

COVID-19 Alters Gut Microbiota

bioxone February 10, 2021February 10, 2021

Souradip Mallick, National Institute of Technology, Rourkela The global COVID-19 pandemic caused by the novel SARS-CoV-2 is still a threat to the human population. As of February 2020, more than 102 million people globally have been infected, and over 2.21 million deaths reported. COVID-19 pandemic has a profuse impact on the economic as well as […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy